Cited by 28

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Cholesterol metabolism and therapeutic targets: Rationale for targeting multiple metabolic pathways

Turley, Stephen D.·2004·Clinical Cardiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/clc.4960271506

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 45

  1. Cook, 1958, Cholesterol. Chemistry, Biochemistry, and Pathology, 145
  2. Vanhanen, 1992, Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man, Metabolism, 41, 588, 10.1016/0026-0495(92)90050-K · DOI
  3. Sudhop, 2002, Inhibition of intestinal cholesterol absorption by ezetimibe in humans, Circulation, 106, 1943, 10.1161/01.CIR.0000034044.95911.DC · DOI · Paper page
  4. Turley, 1988, The Liver: Biology and Pathobiology, 617
  5. Dietschy, 1993, Role of liver in the maintenance of cholesterol and low-density lipoprotein homeostasis in different animal species, including humans, J Lipid Res, 34, 1637, 10.1016/S0022-2275(20)35728-X · DOI · Paper page
  6. Grundy, 2002, Alternative approaches to cholesterol-lowering therapy, Am J Cardiol, 90, 1135, 10.1016/S0002-9149(02)02797-2 · DOI
  7. Tso, 1994, Physiology of the Gastrointestinal Tract, 1867
  8. Phillips, 2000, Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in Type 2 diabetes, Atherosclerosis, 148, 283, 10.1016/S0021-9150(99)00275-0 · DOI
  9. Grundy, 1983, Absorption and metabolism of dietary cholesterol, Ann Rev Nutr, 3, 71, 10.1146/annurev.nu.03.070183.000443 · DOI
  10. Mamo, 1998, Retention of chylomicron remnants by arterial tissue: Importance of an efficient clearance mechanism from plasma, Atherosclerosis, 141, S63, 10.1016/S0021-9150(98)00220-2 · DOI
  11. Turley, 2003, Sterol absorption by the small intestine, Curr Opin Lipidol, 14, 233, 10.1097/00041433-200306000-00002 · DOI
  12. Altmann, 2004, Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption, Science, 303, 1201, 10.1126/science.1093131 · DOI
  13. Berge, 2000, Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters, Science, 290, 1771, 10.1126/science.290.5497.1771 · DOI
  14. Lee, 2001, Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption, Nat Genet, 27, 79, 10.1038/83799 · DOI
  15. Connor, 1974, The intestinal absorption of dietary cholesterol by hypercholesterolemic (type II) and normocholesterolemic humans, J Clin Invest, 53, 1062, 10.1172/JCI107643 · DOI
  16. Nestel, 1975, Increased sterol excretion with polyunsaturated-fat high-cholesterol diets, Metabolism, 24, 189, 10.1016/0026-0495(75)90020-7 · DOI
  17. Crouse, 1982, Effects of AOMA on cholesterol metabolism in man, Metabolism, 31, 733, 10.1016/0026-0495(82)90206-2 · DOI
  18. McMurry, 1985, The absorption of cholesterol and the sterol balance in the Tarahumara Indians of Mexico fed cholesterol-free and high cholesterol diets, Am J Clin Nutr, 41, 1289, 10.1093/ajcn/41.6.1289 · DOI
  19. Briones, 1986, Sterol excretion and cholesterol absorption in diabetics and nondiabetics with and without hyperlipidemia, Am J Clin Nutr, 44, 353, 10.1093/ajcn/44.3.353 · DOI
  20. Kesäniemi, 1987, Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population, Eur J Clin Invest, 17, 391, 10.1111/j.1365-2362.1987.tb01132.x · DOI
  21. McNamara, 1987, Heterogeneity of cholesterol homeostasis in man. Response to changes in dietary fat quality and cholesterol quantity, J Clin Invest, 79, 1729, 10.1172/JCI113013 · DOI
  22. Kern, 1991, Normal plasma cholesterol in an 88-year-old man who eats 25 eggs a day, N Engl J Med, 324, 896, 10.1056/NEJM199103283241306 · DOI
  23. Sehayek, 1998, Ushape relationship between change in dietary cholesterol absorption and plasma lipoprotein responsiveness and evidence for extreme interindividual variation in dietary cholesterol absorption in humans, J Lipid Res, 39, 2415, 10.1016/S0022-2275(20)33320-4 · DOI
  24. Bosner, 1999, Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry, J Lipid Res, 40, 302, 10.1016/S0022-2275(20)33370-8 · DOI
  25. Rajaratnam, 2001, Cholesterol absorption, synthesis, and fecal output in postmenopausal women with and without coronary artery disease, Arterioscler Thromb Vasc Biol, 21, 1650, 10.1161/hq1001.097019 · DOI
  26. Beynen, 1987, Advances in Lipid Research, 115
  27. Schwarz, 2001, Genetic analysis of intestinal cholesterol absorption in inbred mice, J Lipid Res
  28. Sehayek, 2003, Genetic regulation of cholesterol absorption and plasma plant sterol levels: Commonalities and differences, J Lipid Res, 44, 2030, 10.1194/jlr.R300008-JLR200 · DOI
  29. Miettinen, 1998, Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian Simvastatin Survival Study. Finnish 4S Investigators, Br Med J, 316, 1127, 10.1136/bmj.316.7138.1127 · DOI
  30. Grundy, 1971, Interruption of the enterohepatic circulation of bile acids in man: Comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism, J Lab Clin Med, 78, 94
  31. Davidson, 1999, Colesevelam hydrocholoride (Cholestagel). A new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects, Arch Intern Med, 159, 1893, 10.1001/archinte.159.16.1893 · DOI · Paper page
  32. Black, 2002, Gut-acting drugs for lowering cholesterol, Curr Atheroscler Reports, 4, 71, 10.1007/s11883-002-0065-8 · DOI
  33. Katan, 2003, Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels, Mayo Clin Proc, 78, 965, 10.1016/S0025-6196(11)63144-3 · DOI
  34. Crouse, 1979, Effects of sucrose polyester on cholesterol metabolism in man, Metabolism, 28, 994, 10.1016/0026-0495(79)90003-9 · DOI
  35. Kesäniemi, 1984, Turnover of low density lipoproteins during inhibition of cholesterol absorption by neomycin, Arteriosclerosis, 4, 41, 10.1161/01.ATV.4.1.41 · DOI
  36. Knopp, 2003, Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: A pooled analysis from two controlled phase III clinical studies, Int J Clin Pract, 57, 363, 10.1111/j.1742-1241.2003.tb10508.x · DOI
  37. Gagné, 2002, Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia, Circulation, 105, 2469, 10.1161/01.CIR.0000018744.58460.62 · DOI
  38. Gagné, 2002, Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia, Am J Cardiol, 90, 1084, 10.1016/S0002-9149(02)02774-1 · DOI
  39. Salen, 2004, Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia, Circulation, 109, 966, 10.1161/01.CIR.0000116766.31036.03 · DOI
  40. Bruckert, 2002, New advances in lipid-modifying therapies for reducing cardiovascular risk, Cardiology, 97, 59, 10.1159/000057673 · DOI
  41. Sudhop, 2002, Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia, Drugs, 62, 2333, 10.2165/00003495-200262160-00002 · DOI
  42. Ginsberg, 2003, Treatment for patients with the metabolic syndrome, Am J Cardiol, 91, 29E, 10.1016/S0002-9149(02)03386-6 · DOI
  43. Turley, 1997, Identification of a metabolic difference accounting for the hyper- and hyporesponder phenotypes of cynomolgus monkey, J Lipid Res, 38, 1598, 10.1016/S0022-2275(20)37178-9 · DOI
  44. Davidson, 2002, Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia, J Am Coll Cardiol, 40, 2125, 10.1016/S0735-1097(02)02610-4 · DOI
  45. Ballantyne, 2003, Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial, Circulation, 107, 2409, 10.1161/01.CIR.0000068312.21969.C8 · DOI

Cited by

Sorted by citations

Metadata

Authors
Turley, S. D.
Venue
Clinical Cardiology
Publisher
Wiley
Published
2004-06
Volume
27
Issue
S3
Pages
16-21
ISSN
  • 0160-9289
  • 1932-8737
Cited by
28
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review